Leprosy Treatment Market, By Drug Class (Antibacterial, Leprostatics, Antitubercular, Others), By Route Of Administration (Oral, Injectable, Topical), And Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, And Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) - Trends, Analysis, and Forecast till 2030

Report Code: PMI485522 | Publish Date: May 2022 | No. of Pages: 168

Global Leprosy Treatment Market Overview

Leprosy also called as a Hansen’s Disease is a serious medical condition in which person suffered from chronic infection. Leprosy caused by a Mycobacterium leprae bacteria. Leprosy is principally a granulomatous disease & it affects the skin, upper respiratory tract mucosal surfaces, peripheral nerves and the eyes majorly. The symptoms of leprosy include reddish skin lesions, loss of sensation, and weakness of hands and muscles. It is likely to cause nerve damage so as to induce muscle numbness. It is a communicable disease that can propagated through contact with cough or phlegm of the affected person. Generally, it is prevalent in low-income countries & malnutrition as well as weak immune system are other significant risk factors of leprosy. Leprosy can be cured by the Multidrug Therapy (MDT) which includes mixture of drugs like rifampicin, clofazimine and dapsone.  The global leprosy treatment market accounted for US$ 2.65 billion in 2020 and is estimated to be US$ 4.09 billion by 2030 and is anticipated to register a CAGR of 4.50%.

Impact of Covid-19 pandemic on market

In all nations, the COVID-19 pandemic had a substantial impact on health services. WHO report revealed that COVID-19 pandemic has impact on leprosy treatment like reassignment of staff, cessation of community-based activities and active case-finding, delays in receiving MDT supplies at the national level and occasional stock-outs at the subnational and health facility levels, and limited monitoring of nerve function impairment and treatment of reaction. Although this pandemic affected progress of this market in general, but it provided opportunities to enhance digital health initiatives for diagnosis as well as for monitoring & training to strengthen the skills of staffs.

In all nations, the COVID-19 pandemic had a substantial impact on health services. WHO report revealed that COVID-19 pandemic has impact on leprosy treatment like reassignment of staff, cessation of community-based activities and active case-finding, delays in receiving MDT supplies at the national level and occasional stock-outs at the subnational and health facility levels, and limited monitoring of nerve function impairment and treatment of reaction. Although this pandemic affected progress of this market in general, but it provided opportunities to enhance digital health initiatives for diagnosis as well as for monitoring & training to strengthen the skills of staffs.

Global Leprosy Treatment Market Dynamics

Novel Therapies, Government Initiatives & “Towards Zero Leprosy”

Increasing rate of the prevalence of skin diseases increase the demand of Leprosy treatments. Also, government initiatives & favorable reimbursement are propelling factors for growth of the leprosy treatment market. Furthermore, findings of novel therapies also has positive impact on this market. Key companies in the market are focused on various business strategies such as partnership and collaboration & gaining product approvals, in order to provide better solution for leprosy treatment. Additionally, With the help of the Global Leprosy Strategy 2021–2030 “Towards zero leprosy” which was developed through a broad consultative process with all major stakeholders will effect positively on this market in upcoming years.

High cost & Lack of awareness

The high cost of drugs and lack of awareness as well as fear among people is expected to hamper the growth of the market for Leprosy Treatment. However, developing economies with low health care expenditure and least availability of medical facilities for proper diagnosis of diseases are projected to restrain the leprosy treatment market in developing countries during the forecast period.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Leprosy Treatment Market Segmentation

 

Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.

On the basis of Drug Class, the global leprosy treatment market is segmented into Antibacterial, Leprostatics, Antitubercular & Others drugs. Based on Route of Administration leprosy treatment market is divided into Oral, Injectable & Topical. On the basis of Distribution Channel, the market is segmented into Hospitals Pharmacies, Retail Pharmacies, Drug stores and Online Pharmacies.

Regional Insights:

 

Source: Prophecy Market Insights

 

On region the global leprosy treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America has the greatest market for leprosy treatment market, followed by Europe due to favorable reimbursement scenario, high expenditure on health care, rapid adoption of new technologies, rising awareness & high disposable income in the region. Also, Asia-Pacific region is predicted to have a strong growth rate in the leprosy treatment market in the next years because of rising prevalence of leprosy, increasing government initiatives, and rapidly developing health care infrastructure in the region.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2029

Market representation

Revenue in USD Million & CAGR from 2020 – 2029

Market Segmentation

By Drug Class - Antibacterial, Leprostatics, Antitubercular & Others drugs.

By Route of Administration – Oral, Injectable & Topical

By Distribution Channels – Hospitals Pharmacies, Retail Pharmacies, Drug stores & Online Pharmacies.

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the global leprosy treatment market report based on Drug Class, Route of Administration, Distribution Channel and Region.                                                               

 

                                                                                      

Global Oncology Drug Market, By Region:

  • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Leprosy Treatment Market Key Players

The key players operating in the leprosy treatment market includes the prominent player operating in the leprosy treatment market includes GlaxoSmithKline plc, Macleods Pharmaceuticals, Cadila Pharmaceuticals, Novartis AG, Systopic Laboratories Pvt. Ltd., AstraZeneca plc, Zydus Cadila, Merck & Co., Inc., Sanofi & HDT Biotech Corporation.

Global Leprosy Treatment Market Company Profile

  • GlaxoSmithKline plc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Novartis International AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  •   Macleods Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Cadila Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Systopic Laboratories Pvt. Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • AstraZeneca plc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Merck & Co., Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Zydus Cadila
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Sanofi
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • HDT Biotech Corporation.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

 “*” marked represents similar segmentation in other categories in the respective section

Global Leprosy Treatment Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for leprosy treatment Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Drug Class
      • Market Snippet, By Route of Administration
      • Market Snippet, By Distribution Channel
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Leprosy Treatment Market, By Drug Class, 2020 – 2030, (US$ Bn)
    • Overview                                                                        
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Antibacterial
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Leprostatics
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Antitubercular
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global Leprosy Treatment Market, By Route of Administration, 2020 – 2030, (US$ Bn)
    • Overview                                                        
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Oral
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Injectable
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Topical
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Leprosy Treatment Market, By Distribution Channel, 2020 – 2030, (US$ Bn)
    • Overview                                   
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Hospital Pharmacies
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Retail Pharmacies
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Drug Store
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
    • Online Pharmacies
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global Leprosy Treatment Market, By Region, 2020 – 2030, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Bn), By Drug Class, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Route of Administration, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Distribution Channel, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Bn), By Drug Class, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Route of Administration, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Distribution Channel, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Bn), By Drug Class, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Route of Administration, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Distribution Channel, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Bn), By Drug Class, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Route of Administration, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Distribution Channel, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Bn), By Drug Class, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Route of Administration, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Distribution Channel, 2020 – 2030
      • Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  10. Company Profiles

 

  • GlaxoSmithKline plc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Novartis International AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  •   Macleods Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Cadila Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Systopic Laboratories Pvt. Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • AstraZeneca plc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Merck & Co., Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Zydus Cadila
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Sanofi
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • HDT Biotech Corporation.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The global leprosy treatment market is segmented based on Drug Class, Route of Administration, Distribution Channels & Region.

Technological advancements, rising incidence leprosy, increased demand for novel therapies, and newly developed strategy “Towards zero leprosy” to fight against this disease are growing factors of this market.

North America has the greatest market, followed by Europe & also Asia-Pacific region.

GlaxoSmithKline plc, Macleods Pharmaceuticals, Cadila Pharmaceuticals, Novartis AG, Systopic Laboratories Pvt. Ltd., AstraZeneca plc, Zydus Cadila, Merck & Co., Inc., Sanofi & HDT Biotech Corporation.